[email protected]
CAS 372200-56-1 2,6-bis[(4R,5R)-4,5-dihydro-4,5-diphenyl-2-oxazolyl]-Pyridine molecular structure lightbox
CAS RN: 372200-56-1

2,6-bis[(4R,5R)-4,5-dihydro-4,5-diphenyl-2-oxazolyl]-Pyridine

Product Availability

Choose a grade to view its available package options.

4 package records2 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251022 100mg In stock Shanghai Inquiry
Batchno.20250218 100mg / 250mg / 1g Out of stock 5-7 business days Inquiry
Batchno.20250425 1g Out of stock Inquiry
Batchno.20250402 250mg In stock Shanghai Inquiry
  • Product code: SSC-144599
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ＞97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 372200-56-1
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ＞97% 0 Out of Stock Beijing Inquiry

372200-56-1 / (4R,5R)-2-[6-[(4R,5R)-4,5-diphenyl-4,5-dihydro-1,3-oxazol-2-yl]-2-pyridinyl]-4,5-diphenyl-4,5-dihydro-1,3-oxazole

Standard CAS: 372200-56-1 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
372200-56-1
Multi CAS
Yes
Molecular Formula
C35H27N3O2
Molecular Weight
521.600000
Exact Mass
521.210327
InChI
InChI=1S/C35H27N3O2/c1-5-14-24(15-6-1)30-32(26-18-9-3-10-19-26)39-34(37-30)28-22-13-23-29(36-28)35-38-31(25-16-7-2-8-17-25)33(40-35)27-20-11-4-12-21-27/h1-23,30-33H/t30-,31-,32-,33-/m1/s1
InChIKey
SMYDLHVQRYQCDL-XEXPGFJZSA-N

Computed Properties

Structural Parameters

Heavy atom count
40
Aromatic heavy atom count
30
Fraction Csp3
0.11
Rotatable bonds
6
H-bond acceptors
5
Molar refractivity
156.21
TPSA
56.07

LogP / Solubility

WLOGP
7.6
MLOGP
6.73
XLogP3
7
Consensus LogP
7.11
Log S (ESOL)
-8.02
Class (ESOL)
Insoluble
Log S (Ali)
-9.32
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.08
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.51

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
8

Customers Also Viewed

Get In Touch

Contact Us